Skip to main content
Oxurion NV logo

Oxurion NV — Investor Relations & Filings

Ticker · OXUR ISIN · BE0974487192 LEI · 549300VWY8KVDFKLDM59 BR Professional, scientific and technical activities
Open in API
Filings indexed 1,031 across all filing types
Latest filing 2025-09-01 Capital/Financing Update
Country BE Belgium
Listing BR OXUR

About Oxurion NV

https://oxurion.com/

Oxurion NV is a company focused on acquiring majority stakes in European pharmaceutical subcontractors. Its strategy is to build an integrated group of contract service providers to support healthcare stakeholders. A key asset in its portfolio is a majority stake in Axiodis CRO, a contract research organization specializing in biometrics. This investment-based business model represents a strategic pivot from the company's former focus on the internal research and development of therapies for retinal diseases such as Geographic Atrophy (GA) and Age-related Macular Degeneration (AMD).

Recent filings

Filing Released Lang Actions
OXUR-Contrat-atlas-crypto-FR-20250901.pdf
Capital/Financing Update Classification · 100% confidence The document is a press release from Oxurion NV regarding the progress of negotiations for a financing agreement (diversification of treasury). It discusses capital structure and financing activities, which aligns with the 'Capital/Financing Update' category. It is not a full report, but an announcement of a specific corporate financing event.
2025-09-01 French
OXUR-Contrat-atlas-crypto-NL-20250901-1.pdf
Capital/Financing Update Classification · 100% confidence The document is a press release from Oxurion NV regarding the progress of negotiations for a financing agreement (capital structure/funding). It is short (under 5,000 characters) and focuses on the status of a capital-related transaction rather than being a full financial report or a formal regulatory filing. Given the focus on financing activities and capital structure, it fits the 'Capital/Financing Update' category.
2025-09-01 Dutch
OXUR-Transparency-Notification-EN-20250901.pdf
Major Shareholding Notification Classification · 100% confidence The document is a formal announcement from Oxurion NV regarding multiple transparency notifications received from Atlas Special Opportunities II LLC. These notifications detail changes in major shareholding levels (crossing various thresholds such as 10%, 15%, 20%, 25%, and 30%) due to the acquisition or disposal of voting securities. This aligns perfectly with the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels.
2025-09-01 English
OXUR-Transparency-Notification-NL-20250901.pdf
Major Shareholding Notification Classification · 100% confidence The document is a formal 'Transparency Notification' (Transparantiekennisgeving) issued by Oxurion NV regarding changes in shareholding by Atlas Special Opportunities II LLC. It explicitly references the Belgian transparency legislation (Wet van 2 mei 2007) and includes a TR-1 BE form, which is the standard regulatory template for reporting major shareholding thresholds. Since this document reports significant changes in ownership levels (crossing thresholds of 10%, 15%, 20%, 25%, and 30%), it falls under the 'Major Shareholding Notification' category.
2025-09-01 English
OXUR-New-Development-Strategy-EN-20250806.pdf
Legal Proceedings Report Classification · 99% confidence The document is a press release announcing a strategic shift in the company's business model, specifically the termination of an R&D program and a pivot toward CRO activities. It does not fit into specific categories like financial reports, dividend notices, or director dealings. As it is a general corporate announcement regarding business strategy and operations, it falls under the 'Regulatory Filings' (RNS) category as the appropriate fallback for miscellaneous corporate news.
2025-08-07 English
FR_OXURION_PR_New-Development-Strategy_SD_20250806.pdf
Regulatory Filings Classification · 100% confidence The document is a press release from Oxurion NV announcing a strategic shift in its business model, specifically the termination of a R&D program and a focus on CRO activities. It does not fit into specific categories like financial reports, dividend announcements, or director dealings. As it is a general corporate announcement regarding business strategy and operations, it falls under the 'Regulatory Filings' (RNS) category as a catch-all for miscellaneous regulatory disclosures.
2025-08-07 French

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.